European regulators considering Covid-19 vaccines

A bus stop ad for COVID-19 testing is shown outside Pfizer world headquarters in New York on Monday Nov. 9, 2020. (AP Photo/Bebeto Matthews)
A bus stop ad for COVID-19 testing is shown outside Pfizer world headquarters in New York on Monday Nov. 9, 2020. (AP Photo/Bebeto Matthews)

The European Medicines Agency will meet on December 29th to consider Pfizer & BioNTech's vaccine. It could approve Moderna's vaccine by January 12th.

Posted: Dec 1, 2020 8:24 AM

BERLIN (AP) - The European Medicines Agency says it will convene a meeting on Dec. 29 to decide if there is enough data about the safety and efficacy of the COVID-19 vaccine developed by Pfizer and BioNTech for it to be approved.

The agency also said Tuesday it could decide as early as Jan. 12 whether to approve an experimental COVID-19 vaccine developed by Moderna Inc.

The German pharmaceutical company BioNTech and its U.S. partner Pfizer said earlier Tuesday that they had asked the regulator for speeded-up, conditional approval of their coronavirus vaccine, concluding the rolling review process they initiated with the agency in October.

The move comes a day after rival Moderna said it was asking U.S. and European regulators to allow the use of its COVID-19 vaccine.

Huntsville
Clear
43° wxIcon
Hi: 67° Lo: 46°
Feels Like: 43°
Florence
Clear
51° wxIcon
Hi: 70° Lo: 43°
Feels Like: 51°
Fayetteville
Clear
42° wxIcon
Hi: 68° Lo: 43°
Feels Like: 42°
Decatur
Clear
43° wxIcon
Hi: 68° Lo: 47°
Feels Like: 40°
Scottsboro
Clear
38° wxIcon
Hi: 67° Lo: 46°
Feels Like: 38°
WAAY Radar
WAAY WAAY-TV Cam
WAAY Temperatures

Community Events